Now in its 5th year the World Veterinary Vaccine Congress will continue to bring experts from the global animal health industry to discuss scientific, regulatory and commercial issues affecting the veterinary biologics sector. The three day event will feature workshops, presentations, roundtable discussions and panels on Funding & Investment for Animal Health, One Health, AMR, Veterinary Immunology, Vaccine Technology, Delivery, Manufacturing & Biotherapeutics for Companion Animal Diseases.
Co-located with the 20th World Vaccine Congress Europe & 4th Immuno Oncology Profiling Congress. Not limited to vaccines, the event bridges human and animal health, bringing together world class speakers from the veterinary biologics, human vaccine & immuno-oncology industry with both scientific and commercial interests. This holistic approach helps accelerate research & development and collaboration in key areas such as; Innovation, Zoonotic & Transboundary Diseases, Technology Platforms, Vaccines, Clinical Models, Adjuvants & Immunotherapy. With 175+ speakers, 600+ attendees and hundreds of companies in attendance, this is not an event to be missed.
NEW VACCINE TECHNOLOGY AND PLATFORMS
Focused on R&D innovations, this congress will update you of the progression made in veterinary vaccine R&D and vaccine development challenges when developing vaccines against viral, bacterial and parasitic diseases within a variety of animal species. From modified live virus vaccines, DNA vaccines, subunit marker vaccines to novel adjuvanted vaccines, this congress brings all innovation together in one place
BIOPROCESSING, DELIVERY AND MANUFACTURING
Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies
It is imperative for synergy between human and animal health to combat emerging zoonotic & transboundary diseases. Improve knowledge sharing & collaboration with regards to technology, adjuvants & clinical models: What can the human health industry learn from vet & vice versa?
INFLUENZA AND RESPIRATORY
Find ways to improve development of universal influenza, RSV, MERS and TB vaccines
EMERGING AND RE-EMERGING DISEASES
Understand the opportunities for your business in reacting to global threats like Zika, Malaria, Dengue and Ebola
ANTIMICROBIAL RESISTANCE AND EMERGING DISEASES
Expect the unexpected, explore the opportunities and challenges associated with emerging infectious diseases including African swine fever, avian influenza and Rift Valley Fever. Find out how the industry is working together to find alternative routes (vaccines) to slow down the rise of antimicrobial resistance, dengue and Ebola
The World Veterinary Vaccine Congress Europe offers outstanding opportunities for service and solution providers, from senior sponsorship to a range of exhibition booths. If you are looking to gain access to key vaccine decision makers then this is your best ROI in 2019.
Very good organization, interesting mix of talks, good balance between panels and parallel tracks
Head R&D, Marburg GSK Vaccines